Micrornas: Regulators of cancer metastasis and epithelialmesenchymal transition (EMT)

Chinese Journal of Cancer

Volumn 33, Issue 3, 2014, Pages 140-147

  Ding, Xiang Ming ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer metastasis; EMT; Microrna (miRNA)

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MATRIX METALLOPROTEINASE 14; MICRORNA; MICRORNA 124; MICRORNA 153; MICRORNA 155; MICRORNA 197; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 203; MICRORNA 204; MICRORNA 34; TENASCIN; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BIOINFORMATICS; CANCER THERAPY; CELL POLARITY; DNA METHYLATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METASTASIS; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR INVASION; GENE THERAPY; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY; PROCEDURES;

EPITHELIAL-MESENCHYMAL TRANSITION; GENETIC THERAPY; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84896461566     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.013.10094     Document Type: Article

References (109)

1. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science, 2011,331:1559-1564.
2. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer, 2002,2:442-454.
3. Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol, 2011,27:347-376.
4. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest, 2009,119:1420-1428.
5. Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol, 2005,6:622-634.
6. Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res, 2008,68:3645-3654.
7. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer, 2007,7:415-428.
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004,116:281-297.
9. Stahlhut Espinosa CE, Slack FJ. The role of microRNAs in cancer. Yale J Biol Med, 2006,79:131-140.
10. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 2006,6:259-269.
11. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 2008,10:593-601.
12. Park SM, Gaur AB, Lengyel E, et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev, 2008,22:894-907.
13. Korpal M, Lee ES, Hu G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem, 2008,283:14910-14914.
14. Burk U, Schubert J, Wellner U, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep, 2008,9:582-589.
15. Bracken CP, Gregory PA, Kolesnikoff N, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res, 2008,68:7846-7854.
16. Ding X, Park SI, McCauley LK, et al. Signaling between transforming growth factor beta (TGF-beta) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. J Biol Chem, 2013,288:10241-10253.
17. Moes M, Le Bechec A, Crespo I, et al. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS One, 2012,7:e35440.
18. Herschkowitz JI, Zhao W, Zhang M, et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A, 2012,109:2778-2783.
19. Castilla MA, Moreno-Bueno G, Romero-Perez L, et al. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol, 2011,223:72-80.
20. Wellner U, Schubert J, Burk UC, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol, 2009,11:1487-1495.
21. Reinhold WC, Reimers MA, Maunakea AK, et al. Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Mol Cancer Ther, 2007,6:391-403.
22. Zhang Z, Zhang B, Li W, et al. Epigenetic Silencing of miR- 203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells. Genes Cancer, 2011,2:782-791.
23. Tellez CS, Juri DE, Do K, et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res, 2011,71:3087-3097.
24. Wiklund ED, Bramsen JB, Hulf T, et al. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer, 2011,128:1327-1334.
25. Vrba L, Jensen TJ, Garbe JC, et al. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One, 2010,5:e8697.
26. Gregory PA, Bracken CP, Smith E, et al. An autocrine TGF-beta/ ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell, 2011,22:1686-1698.
27. Kim NH, Kim HS, Li XY, et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol, 2011,195:417-433.
28. Kumarswamy R, Mudduluru G, Ceppi P, et al. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int J Cancer, 2012,130:2044-2053.
29. Siemens H, Jackstadt R, Hunten S, et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle, 2011,10:4256-4271.
30. Chang CJ, Chao CH, Xia W, et al. p53 regulates epithelialmesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol, 2011,13:317-323.
31. Kim T, Veronese A, Pichiorri F, et al. p53 regulates epithelialmesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med, 2011,208:875-883.
32. Tao ZH, Wan JL, Zeng LY, et al. miR-612 suppresses the invasivemetastatic cascade in hepatocellular carcinoma. J Exp Med, 2013,210:789-803.
33. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 2008,133:704-715.
34. Morel AP, Lievre M, Thomas C, et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 2008,3:e2888.
35. Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA- 200c links breast cancer stem cells with normal stem cells. Cell, 2009,138:592-603.
36. Ma L, Young J, Prabhala H, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol, 2010,12:247-256.
37. Chen ZL, Zhao XH, Wang JW, et al. microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem, 2011,286:10725-10734.
38. Martello G, Rosato A, Ferrari F, et al. A microRNA targeting dicer for metastasis control. Cell, 2010,141:1195-1207.
39. Stinson S, Lackner MR, Adai AT, et al. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-tomesenchymal transition in breast cancer. Sci Signal, 2011,4:pt5.
40. Kong W, Yang H, He L, et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol, 2008,28:6773-6784.
41. Taylor MA, Sossey-Alaoui K, Thompson CL, et al. TGF-beta up-regulates miR-181a expression to promote breast cancer metastasis. J Clin Invest, 2013,123:150-163.
42. Xia H, Ooi LL, Hui KM. MiR-216a/217-induced epithelialmesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology, 2013,58:629-641.
43. Nicoloso MS, Spizzo R, Shimizu M, et al. MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer, 2009,9:293-302.
44. Valastyan S, Reinhardt F, Benaich N, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 2009,137:1032-1046.
45. Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 2008,451:147-152.
46. Zhang Y, Yang P, Sun T, et al. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol, 2013,15:284-294.
47. Barh D, Malhotra R, Ravi B, et al. MicroRNA let-7: an emerging next-generation cancer therapeutic. Curr Oncol, 2010,17:70-80.
48. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev, 2007,21:1025-1030.
49. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell, 2005,120:635-647.
50. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science, 2007,315:1576-1579.
51. Di Leva G, Piovan C, Gasparini P, et al. Estrogen mediatedactivation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet, 2013,9:e1003311.
52. Kuo PL, Liao SH, Hung JY, et al. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochim Biophys Acta, 2013,1830:3756-3766.
53. Zhu S, Wu H, Wu F, et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res, 2008,18:350-359.
54. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR- 21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 2008,27:2128-2136.
55. Lou Y, Yang X, Wang F, et al. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med, 2010,26:819-827.
56. Cottonham CL, Kaneko S, Xu L. miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem, 2010,285:35293-35302.
57. Liu M, Tang Q, Qiu M, et al. miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett, 2011,585:2998-3005.
58. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 2007,449:682-688.
59. Sasayama T, Nishihara M, Kondoh T, et al. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer, 2009,125:1407-1413.
60. Li QJ, Zhou L, Yang F, et al. MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells. Tumour Biol, 2012,33:1455-1465.
61. Tian Y, Luo A, Cai Y, et al. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem, 2010,285:7986-7994.
62. Weiss FU, Marques IJ, Woltering JM, et al. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology, 2009,137:2136-2145.
63. Huang Q, Gumireddy K, Schrier M, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol, 2008,10:202-210.
64. Liu P, Wilson MJ. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/ Raf/MEK/Erk signaling pathway and NF-kappaB factor in human fibrosarcoma cells. J Cell Physiol, 2012,227:867-876.
65. Korpal M, Ell BJ, Buffa FM, et al. Direct targeting of Sec23a by miR- 200s influences cancer cell secretome and promotes metastatic colonization. Nat Med, 2011,17:1101-1108.
66. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science, 2010,327:198-201.
67. Trang P, Medina PP, Wiggins JF, et al. Regression of murine lung tumors by the let-7 microRNA. Oncogene, 2010,29:1580-1587.
68. Esquela-Kerscher A, Trang P, Wiggins JF, et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle, 2008,7:759-764.
69. Liu C, Kelnar K, Liu B, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med, 2011,17:211-215.
70. Wiggins JF, Ruffino L, Kelnar K, et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res, 2010,70:5923-5930.
71. Ma L, Reinhardt F, Pan E, et al. Therapeutic silencing of miR- 10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol, 2010,28:341-347.
72. Wang FE, Zhang C, Maminishkis A, et al. MicroRNA-204/211 alters epithelial physiology. FASEB J, 2010,24:1552-1571.
73. Liu YN, Yin JJ, Abou-Kheir W, et al. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene, 2013,32:296-306.
74. Xu Q, Sun Q, Zhang J, et al. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis, 2013,34:539-549.
75. Liang YJ, Wang QY, Zhou CX, et al. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis, 2013,34:713-722.
76. Zhang Z, Liu S, Shi R, et al. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet, 2011,204:486-491.
77. Hamada S, Satoh K, Miura S, et al. miR-197 induces epithelialmesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J Cell Physiol, 2013,228:1255-1263.
78. Zhang LY, Liu M, Li X, et al. miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). J Biol Chem, 2013,288:4035-4047.
79. Rice SJ, Lai SC, Wood LW, et al. MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1). J Biol Chem, 2013,288:16348-16360.
80. Sun Q, Zhang J, Cao W, et al. Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int J Biochem Cell Biol, 2013,45:513-520.
81. Yamasaki T, Seki N, Yoshino H, et al. microRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. J Urol, 2013,190:1059-1068.
82. Chou J, Lin JH, Brenot A, et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA- 29b expression. Nat Cell Biol, 2013,15:201-213.
83. Ding J, Huang S, Wang Y, et al. Genome-wide screening revealed that miR-195 targets the TNF-alpha/NF-kappaB pathway by downregulating IKKalpha and TAB3 in hepatocellular carcinoma. Hepatology, 2013,58:654-666.
84. Xu X, Fan Z, Kang L, et al. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest, 2013, 123:630-645.
85. Goldberger N, Walker RC, Kim CH, et al. Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene arid4b. Cancer Res, 2013,73:2671-2681.
86. Liang L, Li X, Zhang X, et al. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Gastroenterology, 2013,144:624-635.
87. Yeh YM, Chuang CM, Chao KC, et al. MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1alpha. Int J Cancer, 2013,133:867-878.
88. Yang H, Fang F, Chang R, et al. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma. Hepatology, 2013,58:205-217.
89. Noguchi S, Mori T, Hoshino Y, et al. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett, 2011,307:211-220.
90. Ni Y, Meng L, Wang L, et al. MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene, 2013,517:197-204.
91. Ishteiwy RA, Ward TM, Dykxhoorn DM, et al. The microRNA-23b/ -27b cluster suppresses the metastatic phenotype of castrationresistant prostate cancer cells. PLoS One, 2012,7:e52106.
92. Okuda H, Xing F, Pandey PR, et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res, 2013,73:1434-1444.
93. Yu L, Lu J, Zhang B, et al. miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2. Oncol Lett, 2013,5:1223-1228.
94. Liu N, Tang LL, Sun Y, et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer Lett, 2013,329:181-188.
95. Zhong M, Bian Z, Wu Z. miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. Cell Physiol Biochem, 2013,31:209-218.
96. Dynoodt P, Speeckaert R, De Wever O, et al. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells. Int J Oncol, 2013,42:1443-1451.
97. Yang XW, Zhang LJ, Huang XH, et al. miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17. Hepatol Res, 2013 Apr 28. [Epub ahead of print]
98. Zhao G, Zhang JG, Liu Y, et al. miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKalpha1. Mol Cancer Ther, 2013,12:83-93.
99. Wu X, Liu T, Fang O, et al. miR-194 suppresses metastasis of nonsmall cell lung cancer through regulating expression of BMP1 and p27. Oncogene, 2013 Apr 15. [Epub ahead of print]
100. Yu YH, Chen HA, Chen PS, et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene, 2013,32:431-443.
101. Li B, Song Y, Liu TJ, et al. miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9. Oncol Rep, 2013,29:1932-1938.
102. Xu C, Zeng Q, Xu W, et al. miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR. Mol Cancer Ther, 2013,12:207-219.
103. Kliese N, Gobrecht P, Pachow D, et al. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene, 2012 Oct 29. [Epub ahead of print]
104. Zheng L, Pu J, Qi T, et al. miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells. Mol Cancer Res, 2013,11:182-193.
105. Iino I, Kikuchi H, Miyazaki S, et al. Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis. Cancer Sci, 2013,104:624-630.
106. Pencheva N, Tran H, Buss C, et al. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell, 2012,151:1068-1082.
107. Tian Q, Liang L, Ding J, et al. MicroRNA-550a acts as a prometastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma. PLoS One, 2012,7:e48958.
108. Du WW, Fang L, Li M, et al. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. J Cell Sci, 2013,126:1440-1453.
109. Fang L, Du WW, Yang W, et al. miR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle, 2012,11:4352-4365.